Equillium announces oral presentation at the tandem meetings of astct and cibmtr

La jolla, calif.--(business wire)---- $eq #gvhd--equillium, inc. (nasdaq: eq), a clinical-stage biotechnology company focused on developing novel therapeutics to treat severe autoimmune and inflammatory disorders, today announced that an oral presentation was given yesterday afternoon at the tandem meetings of the american society of transplantation and cellular therapy, and the center for international blood & marrow transplant research. the oral presentation, given by dr.
EQ Ratings Summary
EQ Quant Ranking